News

FDA approves first RSV vaccine for adults 60 and older

By Brady Knox
Published May 3, 2023 8:38pm ET
Add Washington Examiner on Google
FDA approves first RSV vaccine for adults 60 and older
US FDA Approves GSK’s AREXVY, the World’s First Respiratory Syncytial Virus (RSV) Vaccine for Older Adults. (Business Wire) | Business Wire

The Food and Drug Administration has approved the first-ever vaccine for respiratory syncytial virus, better known as RSV.

Print subscriber? Click here to login/register your account
Digital subscriber? Click here to login/register your account.

Trusted reporting.Unlimited access.

Subscribe for full access to Washington Examiner coverage, expert political analysis, and subscriber-only journalism.

Get Unlimited Access

Already a member? Log in

Cancel anytime.

Tag:

FDA Health Public Health Vaccines